Articles by Disease (Cerebellar Diseases)

Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16
Page: 1099-1110
Author(s): Jeffrey M. Witkin*, Douglas A. Schober, Scott D. Gleason, John T. Catlow, Warren J. Porter, Jon Reel, Xiaoming Jin, Jonathan Hobbs, Donald Gehlert, Douglas L. Gernert, Kevin M. Gardinier, Akihiko S. Kato, Xingjie Ping and Jodi L. Smith

Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells (NF-κB) – a Friend, a Foe, or a Bystander - in the Neurodegenerative Cascade and Pathogenesis of Alzheimer's Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16
Page: 1050-1065
Author(s): Gurdeep Marwarha and Othman Ghribi*

PPARs in Neurodegenerative and Neuroinflammatory Pathways

Journal: Current Alzheimer Research
Volume: 15
Page: 336-344
Author(s): E. Benedetti, L. Cristiano, A. Antonosante, M. d'Angelo, B. d'Angelo, S. Selli, V. Castelli, R. Ippoliti, A. Giordano and A. Cimini*

HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation

Journal: Current Cancer Drug Targets
Volume: 18
Page: 287-294
Author(s): Gustavo Alencastro Veiga Cruzeiro, Maristella Bergamo dos Reis, Vanessa Silva Silveira, Regia Caroline Peixoto Lira, Carlos Gilberto Carlotti Jr, Luciano Neder, Ricardo Santos Oliveira, Jose Andres Yunes, Silvia Regina Brandalise, Simone Aguiar, Agda Karina Eterovic, Luiz Gonzaga Tone, Carlos Alberto Scrideli* and Elvis Terci Valera

Articles by Disease (Cerebellar Diseases)

Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)

Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells (NF-κB) – a Friend, a Foe, or a Bystander - in the Neurodegenerative Cascade and Pathogenesis of Alzheimer's Disease

PPARs in Neurodegenerative and Neuroinflammatory Pathways

HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation

CT and MR Imaging of the Encephalopathic Child

2-Hydroxypropyl-β-cyclodextrins and the Blood-Brain Barrier: Considerations for Niemann-Pick Disease Type C1

Treatment of Epileptic Encephalopathies

Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis

Modulation of GABAA Receptors in the Treatment of Epilepsy

Experimental Treatment Options in Absence Epilepsy